Athanasios Chris Karamesines – Trademark Portfolio

Entity Type: 01

Athanasios Chris Karamesines holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include VIVERE, VIVERE TO LIVE, COLLECTIVE LOTION, YOUR INDIVIDUALITY, and SENSUOUS ENHANCEMENT ACCELERATOR INHALANT. The owner is based in Muncie, IN.

1600 University Avenue

Muncie, IN 47303

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Athanasios Chris Karamesines's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Athanasios Chris Karamesines have?

Athanasios Chris Karamesines has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned.

What trademark classes does Athanasios Chris Karamesines file in?

Athanasios Chris Karamesines files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Athanasios Chris Karamesines's most well-known trademarks?

Athanasios Chris Karamesines's registered trademark portfolio includes well-known marks such as VIVERE, VIVERE TO LIVE, COLLECTIVE LOTION, YOUR INDIVIDUALITY, and SENSUOUS ENHANCEMENT ACCELERATOR INHALANT. These are among 5 currently registered trademarks in the portfolio.

What is Athanasios Chris Karamesines's trademark registration success rate?

Athanasios Chris Karamesines has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.